Cargando…

Integrating GWAS with gene expression data to dissect the genetic architecture of triple-negative breast cancer

Detalles Bibliográficos
Autores principales:	Hicks, Chindo, Kumar, Ranjit, Pannuti, Antonio, Miele, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439042/ http://dx.doi.org/10.1186/gb-2011-12-s1-p35

Ejemplares similares

An integrative genomics approach for mapping the emerging genetic susceptibility landscape of triple-negative breast cancer
por: Hicks, Chindo, et al.
Publicado: (2012)

An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer
por: Hicks, Chindo, et al.
Publicado: (2013)

Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
por: Hicks, Chindo, et al.
Publicado: (2012)

Associating GWAS Information with the Notch Signaling Pathway Using Transcription Profiling
por: Hicks, Chindo, et al.
Publicado: (2011)

An Integrative Genomics Approach to Biomarker Discovery in Breast Cancer
por: Hicks, Chindo, et al.
Publicado: (2011)

Novel Integrative Genomics Approach for Associating GWAS Information with Intrinsic Subtypes of Breast Cancer
por: Hicks, Chindo, et al.
Publicado: (2013)

Whole Genome Transcriptome Analysis of the Association between Obesity and Triple-Negative Breast Cancer in Caucasian Women
por: Mamidi, Tarun K. K., et al.
Publicado: (2018)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2019)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors
por: Pannuti, Antonio, et al.
Publicado: (2018)

Dissecting the genetic architecture of coronary artery disease by genome engineering
por: Segal, David J, et al.
Publicado: (2012)

Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2019)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Comprehensive Assessment and Network Analysis of the Emerging Genetic Susceptibility Landscape of Prostate Cancer
por: Hicks, Chindo, et al.
Publicado: (2013)

In vitro antineoplastic activity in triple-negative breast cancer cell line and in vivo
por: Madeira, Klesia, et al.
Publicado: (2014)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

Phenotypic analysis of breast cell lines – triple negative cells vs expressing hormonal receptors
por: Laranjo, Mafalda, et al.
Publicado: (2010)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
por: Bouchalova, K, et al.
Publicado: (2011)

In vivo pulmonary metastatic profile of breast cancer cell lines expressing hormonal receptors versus triple negative
por: Carvalho, M João, et al.
Publicado: (2010)

Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON
por: Hu, Zhiwei, et al.
Publicado: (2015)

TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer
por: Byrd, Tiara, et al.
Publicado: (2014)

PB.53: Are ethnic minorities more likely to develop triple-negative breast cancer? A systematic review
por: Limbada, R, et al.
Publicado: (2013)

HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
por: Lyu, Hui, et al.
Publicado: (2023)

Dirichlet process model for joint haplotype inference and GWAS
por: Sahu, Avinash Das, et al.
Publicado: (2012)

A retrospective review of triple-negative breast cancer cases: are there common features in the clinical presentation, imaging and risk factors?
por: Trevett, N, et al.
Publicado: (2010)

Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer
por: Hossain, Fokhrul, et al.
Publicado: (2021)

An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer Phenotypes
por: Hicks, Chindo, et al.
Publicado: (2017)

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
por: Hossain, Fokhrul, et al.
Publicado: (2023)

Association of Genetic Polymorphisms in STAT 3, STAT 5b and GWAS Identified PTPN22 Gene with Rheumatic Heart Disease
por: Gupta, Usha, et al.
Publicado: (2014)

Genetic dissection of quantitative epigenomic variation in yeast
por: Abraham, Anne-Laure, et al.
Publicado: (2013)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
por: Hossain, Fokhrul, et al.
Publicado: (2021)

An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer
por: Ryall, Karen A, et al.
Publicado: (2015)

Integrating GWAS and TWAS to elucidate the genetic architecture of maize leaf cuticular conductance
por: Lin, Meng, et al.
Publicado: (2022)

Elucidating the molecular genetic basis of cluster headache: delineation of the genetic architecture by exome sequencing
por: Southgate, L, et al.
Publicado: (2013)

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
por: Sainsbury, R, et al.
Publicado: (2010)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_43buj2eqhsmm6ubed9qpsebvaf